PMID- 19763153 OWN - NLM STAT- MEDLINE DCOM- 20091008 LR - 20240321 IS - 1471-0064 (Electronic) IS - 1471-0056 (Print) IS - 1471-0056 (Linking) VI - 10 IP - 10 DP - 2009 Oct TI - Causes and consequences of microRNA dysregulation in cancer. PG - 704-14 LID - 10.1038/nrg2634 [doi] AB - Over the past several years it has become clear that alterations in the expression of microRNA (miRNA) genes contribute to the pathogenesis of most--if not all--human malignancies. These alterations can be caused by various mechanisms, including deletions, amplifications or mutations involving miRNA loci, epigenetic silencing or the dysregulation of transcription factors that target specific miRNAs. Because malignant cells show dependence on the dysregulated expression of miRNA genes, which in turn control or are controlled by the dysregulation of multiple protein-coding oncogenes or tumour suppressor genes, these small RNAs provide important opportunities for the development of future miRNA-based therapies. FAU - Croce, Carlo M AU - Croce CM AD - Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, 410 West 10th Avenue, Columbus, OH 43210, USA. carlo.croce@osumc.edu LA - eng GR - P01 CA076259/CA/NCI NIH HHS/United States GR - P01 CA076259-050001/CA/NCI NIH HHS/United States GR - P01 CA129242/CA/NCI NIH HHS/United States PT - Journal Article PT - Review PL - England TA - Nat Rev Genet JT - Nature reviews. Genetics JID - 100962779 RN - 0 (MicroRNAs) SB - IM MH - Animals MH - Gene Expression Regulation, Neoplastic/*physiology MH - Humans MH - MicroRNAs/*genetics MH - Neoplasms/*genetics PMC - PMC3467096 MID - NIHMS197508 EDAT- 2009/09/19 06:00 MHDA- 2009/10/09 06:00 PMCR- 2012/10/09 CRDT- 2009/09/19 06:00 PHST- 2009/09/19 06:00 [entrez] PHST- 2009/09/19 06:00 [pubmed] PHST- 2009/10/09 06:00 [medline] PHST- 2012/10/09 00:00 [pmc-release] AID - nrg2634 [pii] AID - 10.1038/nrg2634 [doi] PST - ppublish SO - Nat Rev Genet. 2009 Oct;10(10):704-14. doi: 10.1038/nrg2634.